ABCSG R05 Summary
Pre-operative induction-chemotherapy in combination with bevacizumab followed by combined radio-chemotherapy of local progressive rectal cancer with high relapse risk – a phase-II-pilot-study with pre-operative capecitabine (Xeloda®), oxaliplatin and bevacizumab (Avastin®), followed by capecitabine (Xeloda®) plus radiotherapy (RTx).
|Coordinating investigators:||Eisterer, Wolfgang; Innsbruck
De Vries, Alexander; Feldkirch
Öfner, Dietmar; Salzburg
(Click to enlarge)